Latest International Expansion News

Spacetalk Ltd reports robust 3QFY25 results, showcasing strong revenue growth and a sharp reduction in losses as it pivots to a subscription-driven family safety platform.

Gentrack reported a solid 9.8% revenue increase to NZ$112 million in HY25, driven by recurring revenue growth and international expansion, while net profit after tax surged 34.7%. The company’s outlook remains optimistic as it targets FY25 revenue above NZ$230 million and deeper market penetration across Asia, Europe, and the Middle East.

Life360’s Q1 2025 results reveal robust revenue growth, expanding profitability, and a bullish outlook for FY 2025, driven by a scalable freemium model and international expansion.

Life360 has reported a landmark first quarter in 2025, with soaring user engagement and robust revenue growth that underscore its resilience in a cautious consumer market.

Wellnex Life Limited reports a robust 46% revenue increase and successful AIM listing, setting the stage for UK and European expansion.

hummgroup announces the resignation of CEO Stuart Grimshaw for personal reasons, with Angelo Demasi appointed as his immediate successor to lead the company’s next growth phase.

Acrux Limited has appointed John Warmbrunn as its new CEO and Managing Director, signaling a strategic push for international expansion and product development starting June 2025.

Kelsian Group signals a cautious FY25 outlook with EBITDA tracking at the lower end of guidance, while advancing strategic tourism divestments and securing key contract renewals.

Latrobe Magnesium Limited has successfully closed an oversubscribed Share Purchase Plan, raising $836,800 to fund its Demonstration Plant operations in Victoria. This capital injection supports the company’s pioneering sustainable magnesium extraction efforts.

Eden Innovations’ US subsidiary has secured its first EdenCrete®Pz7 order from Holcim Mexico, marking the product’s expansion to three countries within the Holcim Group’s concrete operations.

SPC Global Holdings confirms FY2025 pro forma EBITDA guidance of A$29 million, driven by strong early post-merger performance and strategic initiatives including site consolidation and leadership renewal.

Beamtree Holdings has landed a landmark NHS contract and multiple international deals, positioning itself for robust annual recurring revenue growth and improved profitability by the end of FY25.